- Home
- UTL vs OLMA Comparison
UTL vs OLMA Comparison
Compare UTL & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UTL | OLMA |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United States |
| Employees | N/A | 137 |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.9M | 1.1B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | UTL | OLMA |
|---|---|---|
| Price | $53.62 | $12.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $56.50 | $44.89 |
| AVG Volume (30 Days) | 90.3K | ★ 863.3K |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | 1.37 | ★ 15.00 |
| EPS | ★ 2.11 | N/A |
| Revenue | ★ $536,000,000.00 | N/A |
| Revenue This Year | $5.43 | N/A |
| Revenue Next Year | $4.22 | N/A |
| P/E Ratio | $25.46 | ★ N/A |
| Revenue Growth | ★ 8.33 | N/A |
| 52 Week Low | $45.11 | $4.92 |
| 52 Week High | $57.26 | $36.26 |
Technical Indicators
Market Signals| Indicator | UTL | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 49.96 | 51.82 |
| Support Level | $50.41 | $10.71 |
| Resistance Level | $57.26 | $12.81 |
| Average True Range (ATR) | 1.43 | 0.61 |
| MACD | -0.26 | 0.01 |
| Stochastic Oscillator | 36.40 | 59.89 |
Price Performance
Historical ComparisonAbout UTL UNITIL Corporation
Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.